graph EGM comparisons
pembrolizumab alonetitlepembrolizumab (10mg/kg)titlepembrolizumab (2mg/kg)titleStandard of Care (SoC)titledocetaxeltitleKEYNOTE-042 (PDL1>20%), 2019 NCT02220894 mNSCLC - L1 - PDL1 positive 413/405KEYNOTE-042 (PDL1>1%), 2019 NCT02220894 mNSCLC - L1 - PDL1 positive 637/637KEYNOTE-024 (PDL1>50%), 2016 NCT02142738 mNSCLC - L1 - PDL1 positive 154/151KEYNOTE-042 (PDL1>50%), 2019 NCT02220894 mNSCLC - L1 - PDL1 positive 299/300KEYNOTE-010 (P:10 mg/kg), 2016 NCT01905657 mNSCLC - L2 - PDL1 positive 346/343KEYNOTE-010 (P:10 mg/kg ; PDL1>50%), 2016 NCT01905657 mNSCLC - L2 - PDL1 positive 151/152KEYNOTE-010 (P: 2mg/kg ; PDL1>50%), 2016 NCT01905657 mNSCLC - L2 - PDL1 positive 139/152KEYNOTE-010 (P: 2mg/kg), 2016 NCT01905657 mNSCLC - L2 - PDL1 positive 344/343

Pathology:  mNSCLC - L1 - PDL1 positive;   mNSCLC - L2 - PDL1 positive; 

mNSCLC - L1 - PDL1 positivemNSCLC - L2 - PDL1 positive
KEYNOTE-042 (PDL1>20%), 2019KEYNOTE-042 (PDL1>1%), 2019KEYNOTE-024 (PDL1>50%), 2016KEYNOTE-042 (PDL1>50%), 2019KEYNOTE-010 (P:10 mg/kg), 2016KEYNOTE-010 (P:10 mg/kg ; PDL1>50%), 2016KEYNOTE-010 (P: 2mg/kg ; PDL1>50%), 2016KEYNOTE-010 (P: 2mg/kg), 2016
pembrolizumab alone4T1T1T1T1
pembrolizumab (10mg/kg)2T1T1
pembrolizumab (2mg/kg)2T1T1
Standard of Care (SoC)0T0T0T0T0
docetaxel0T0T0T0T0